Titan Pharmaceuticals
TTNP
#10775
Rank
NZ$10.78 M
Marketcap
NZ$8.11
Share price
-3.76%
Change (1 day)
23.54%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.72. In 2023 the company made an earnings per share (EPS) of NZ-$13.03 an increase over its 2022 EPS that were of NZ-$26.71.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$13.03-51.22%
2022NZ-$26.71-15.61%
2021NZ-$31.65-81.37%
2020NZ-$169.84-77.52%
2019NZ-$755.67-56.32%
2018NZ-$1,730-59.51%
2017NZ-$4,273-371.81%
2016NZ$1,572-144.35%
2015NZ-$3,545300%
2014NZ-$886.14-121.54%
2013NZ$4,114-151.38%
2012NZ-$8,007-11.54%
2011NZ-$9,051188.89%
2010NZ-$3,133-10%
2009NZ-$3,481
2007NZ-$14,273-2.38%
2006NZ-$14,621-39.13%
2005NZ-$24,021-16.87%
2004NZ-$28,895-22.43%
2003NZ-$37,2504.9%
2002NZ-$35,50961.9%
2001NZ-$21,932-13.7%
2000NZ-$25,41365.01%
1999NZ-$15,401-35.87%
1998NZ-$24,017-1824.71%
1997NZ$1,393-102.4%
1996NZ-$58,137

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.36-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.34-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$2.50-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.62-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.44-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.84-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA